Back to search

Article

Identification and Engineering of Aptamers for Theranostic Application in Human Health and Disorders

2020-12-17

Abstract excerpt

Aptamer is short sequence of synthetic oligonucleotides which bind to their cognate target specifically while maintaining similar or higher sensitivity as antibody. Small size, chemical synthesis, low batch variation, cost effectiveness, long shelf life and above all low immunogenicity provide advantages over antibody. The in-vitro selection of aptamer applying a conjoining approach of chemistry and molecular biol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1f0264fb-1c73-5778-80e2-48abdeb492f9
DOI
10.22541/au.160823724.47148190/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification and Engineering of Aptamers for Theranostic Application in Human Health and DisordersDOI 10.22541/au.160823724.47148190/v1
Nucleic Acid-Based Aptamers: Applications, Development and Clinical TrialsSemantic proximity
Aptamer-Based Probes for Cancer Diagnostics and TreatmentSemantic proximity
Therapeutic Applications of AptamersSemantic proximity
Aptamers: An Emerging Class of Molecules That Rival Antibodies in DiagnosticsSemantic proximity
A Highlight of Recent Advances in Aptamer Technology and Its ApplicationSemantic proximity
Aptamers and antibodies: rivals or allies in cancer targeted therapy?Semantic proximity
Aptamer Applications in Emerging Viral DiseasesSemantic proximity
Rethinking Aptamers as Nanotheranostic Tools for SARS-COV-2 and COVID-19 InfectionSemantic proximity
Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseasesSemantic proximity
Aptamer-based technology for radionuclide targeted imaging and therapy: a promising weapon against cancerSemantic proximity
The 20th Anniversary of Pegaptanib (MacugenTM), the First Approved Aptamer Medicine: History, Recent Advances and Future Prospects of Aptamers in TherapySemantic proximity
Aptamers Against Cell Surface Receptors: Selection, Modification and ApplicationSemantic proximity
Select a neighboring publication to make it the new centre.